Tested Applications
| Positive WB detected in | NCI-H1299 cells, mouse pancreas tissue, mouse adipose tissue, rat liver tissue |
| Positive IHC detected in | mouse pancreas tissue, human breast cancer tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:750-1:3000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14109-1-AP targets SEPHS2 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, goat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag5255 Product name: Recombinant human SEPHS2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 118-448 aa of BC016643 Sequence: GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLLSVSQSMSEEEREKVTPLMVKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQPNEFIMPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKVKMVVSREEVELAYQEAMFNMATLNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAVSKASGRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARIIDKPRVIEVLPRGATAAVLAPDSSNASSEPSS Predict reactive species |
| Full Name | selenophosphate synthetase 2 |
| Calculated Molecular Weight | 47 kDa |
| Observed Molecular Weight | 47-50 kDa |
| GenBank Accession Number | BC016643 |
| Gene Symbol | SEPHS2 |
| Gene ID (NCBI) | 22928 |
| RRID | AB_2878014 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q99611 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SEPHS2 (Selenophosphate synthetase 2), a selenophosphate synthetase, catalyzes the conversion of selenite and adenosine triphosphate (ATP) into selenophosphate. SEPHS2 is the rate-limiting enzyme that converts selenite to selenocysteine, a key substance in the synthesis of many selenium proteins such as glutathione peroxidase, thioredoxin reductase, and formate dehydrogenase (PMID: 40750759, 31695102).
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SEPHS2 antibody 14109-1-AP | Download protocol |
| WB protocol for SEPHS2 antibody 14109-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
SEPHS2 Polyclonal antibody (Cat# 14109-1-AP) has 12 citations published in journals including Molecular Cell, Nature Structural & Molecular Biology, Redox Biology, Biomaterials, Cell Death & Disease, EMBO Molecular Medicine, Cell Reports, Journal of Nanobiotechnology, Scientific Reports, Journal of Dairy Science, and Frontiers in Medicine. Associated research fields span ferroptosis, selenoprotein synthesis, cancer biology (hepatocellular carcinoma, breast cancer, multiple myeloma, pancreatic cancer, osteosarcoma), wound healing, atherosclerosis, and mastitis.
| Species | Application | Title |
|---|---|---|
Redox Biol Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition | ||
Mol Cell PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization | ||
Mol Cell Hypoxia-driven lncRNA SHIELD promotes GPX4 translation and protects against ferroptosis in hepatocellular carcinoma. | ||
J Nanobiotechnology Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles. | ||
Biomaterials H2Se-evolving bio-heterojunctions promote cutaneous regeneration in infected wounds by inhibiting excessive cellular senescence | ||
Cell Death Dis METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression |















